On June 27, the corneal storage solution developed by the team at the Affiliated Eye Hospital of Shandong First Medical University and manufactured by Shandong Biodear Medical Devices Co., Ltd. (“Biodear”) officially received approval from…
Molecular Glues: Unique Mechanism Of Action Wide Market Prospects Earlier this year, AbbVie announced a partnership with biotech company Neomorph for more than $1.6 billion to develop novel molecular glues protein degraders on multiple targets…
Introduction Amvuttra dosing (vutrisiran) is a new-generation RNA interference (RNAi) therapy used for the treatment of polyneuropathy in adult patients with hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis). This rare and progressive disease affects the nerves, heart,…
Novo Nordisk announced that its innovative growth hormone analogue Sogroya® (somapacitan) has been approved by the US Food and Drug Administration (FDA) for the treatment of growth hormone deficiency (GHD) in adults and children. As…
In a world still grappling with neglected tropical diseases, Impavido (generic name: miltefosine) remains one of the few oral treatments available for leishmaniasis, a parasitic infection that affects millions in impoverished and underserved regions. Despite…
Imdelltra™ (tarlatamab-dlle) represents a significant advancement in the treatment of extensive-stage small cell lung cancer (ES-SCLC), a particularly aggressive form of lung cancer. Developed by Amgen, this novel therapy received accelerated approval from the U.S.…
HYMPAVZI is the first and only anti-tissue factor pathway inhibitor (anti-TFPI) approved in the U.S. for the treatment of hemophilia A or B and the first hemophilia medicine approved in the U.S. to be administered…
Fampyra, known generically as fampridine or 4-aminopyridine, is an oral medication approved to improve walking ability in adults with multiple sclerosis (MS) who experience walking disabilities. It functions as a potassium channel blocker, aiming to…
In the ongoing battle against antimicrobial resistance, Fetroja (cefiderocol) has emerged as a promising solution for treating complicated infections caused by multidrug-resistant Gram-negative bacteria. Developed by Shionogi & Co.,Ltd., this innovative siderophore cephalosporin antibiotic has…
Antizol, the brand name for fomepizole, is an essential antidote used in the treatment of ethylene glycol and methanol poisoning. These toxic alcohols are commonly found in antifreeze, solvents, and various household products. Without prompt…
In 2025, Dupixent (dupilumab), developed by Sanofi and Regeneron, continues to solidify its position as a leading treatment for various inflammatory diseases. Recent FDA approvals and impressive sales figures underscore its growing significance in the…
Calcort, the trade name for deflazacort in the United Kingdom, has been a cornerstone in the management of Duchenne Muscular Dystrophy (DMD) for decades. As a glucocorticoid with anti-inflammatory and immunosuppressive properties, deflazacort offers therapeutic…
